-
1دورية أكاديمية
المؤلفون: Cortellini, Alessio, Ricciuti, Biagio, Facchinetti, Francesco, Alessi, João Victor Machado, Venkatraman, Deepti, Dall'Olio, Filippo G, Cravero, Paola, Vaz, Victor R, Ottaviani, Diego, Majem, Margarita, Piedra, Aida, Sullivan, Ivana, Lee, Karla A, Lamberti, Giuseppe, Hussain, Nadiya, Clark, Jeffrey, Bolina, Anita, Barba, Andrés, Benitez, José Carlos, GorrÃa, Teresa, Mezquita, Laura, Hoton, Delphine, Aboubakar Nana, Frank, Besse, Benjamin, Awad, Marc M, Pinato, David J
المساهمون: UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de pneumologie, UCL - (SLuc) Service d'anatomie pathologique
المصدر: Annals of oncology, Vol. 32, no.11, p. 1391-1399 (2021)
مصطلحات موضوعية: Anti-Bacterial Agents, Carcinoma, Non-Small-Cell Lung, Humans, Immunotherapy, Lung Neoplasms, Treatment Outcome, antibiotics, chemotherapy, immune checkpoint inhibitors, non-small-cell lung cancer, pembrolizumab, predictive factors
العلاقة: boreal:253218; http://hdl.handle.net/2078.1/253218Test; info:pmid/34400292; urn:ISSN:0923-7534; urn:EISSN:1569-8041
-
2دورية أكاديمية
المؤلفون: Cortellini, Alessio, Ricciuti, Biagio, Facchinetti, Francesco, Alessi, João Victor Machado, Venkatraman, Deepti, Dall'Olio, Filippo G, Cravero, Paola, Vaz, Victor R, Ottaviani, Diego, Majem, Margarita, Piedra, Aida, Sullivan, Ivana, Lee, Karla A, Lamberti, Giuseppe, Hussain, Nadiya, Clark, Jeffrey, Bolina, Anita, Barba, Andrés, Benitez, José Carlos, GorrÃa, Teresa, Mezquita, Laura, Hoton, Delphine, Aboubakar Nana, Frank, Besse, Benjamin, Awad, Marc M, Pinato, David J
المساهمون: UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service de pneumologie, UCL - (SLuc) Service d'anatomie pathologique
المصدر: Annals of oncology, Vol. 32, no.11, p. 1391-1399 (2021)
مصطلحات موضوعية: Anti-Bacterial Agents, Carcinoma, Non-Small-Cell Lung, Humans, Immunotherapy, Lung Neoplasms, Treatment Outcome, antibiotics, chemotherapy, immune checkpoint inhibitors, non-small-cell lung cancer, pembrolizumab, predictive factors
العلاقة: boreal:253218; http://hdl.handle.net/2078.1/253218Test; info:pmid/34400292; urn:ISSN:0923-7534; urn:EISSN:1569-8041